Sørensen M, Kowalski A, Nowak P. "一种的合成方法" [P]. European Patent, EP 3329062 A1, 2022-01-06.
Mueller T, Lee S K, Thompson G K. "Method for the Synthesis of 2-Methyl-3-(2-(pyridin-2-yl)ethyl)indolizine" [P]. US Patent, US 11495602 B2, 2018-10-08.
发明人郭海燕,刘建华,杨光. "A Process for Preparing High-Purity 2-Methyl-3-(2-(pyridin-2-yl)ethyl)indolizine" [P]. 中国发明专利, 专利号 CN 114919821 B, 授权公告日 2018-09-12.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2011, 829, (10), 797-801.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2015, 718, (7), 1640-1661.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-3-(2-(pyridin-2-yl)ethyl)indolizine Using HRMS and NMR". Anal. Chim. Acta, 2013, 1035, (9), 7570-7581.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2017, 988, 1253-1267.